• Global IVD Antibody Raw Materials market size was valued at USD 1,315 million in 2024. The market is projected to grow from USD 1,393 million in 2025 to USD 1,963 million by 2032, exhibiting a CAGR of 6.0% during the forecast period.
Email:
• IVD (In Vitro Diagnostic) Antibody Raw Materials are specialized biological components essential for developing diagnostic tests. These materials include monoclonal antibodies, polyclonal antibodies, and recombinant antibodies designed to detect specific biomarkers, pathogens, or disease-related antigens in patient samples. They serve as critical building blocks for diagnostic assays across ELISA, lateral flow tests, chemiluminescence immunoassays (CLIA), and other platforms. The accuracy and sensitivity of these raw materials directly influence the reliability of diagnostic results, making them indispensable in clinical laboratories and point-of-care testing.
Email: help@intelmarketresearch.com +91 9169164321
By Types
•Infectious
Diseases
•Oncology
•Diabetes
•Cardiovascular Diseases
• Immunoassays
• Point-of-Care Testing (POCT)
• Molecular Diagnostics
• Clinical Chemistry
• Hematology
Email: help@intelmarketresearch.com +91
